CME Group to Launch CME Securities Clearing on December 7 to Expand Clearing Capacity, Choice and Capital Efficiency in the U.S. Treasury Market

CME Group (CME) named Jack Tobin as its next CFO, succeeding Lynne Fitzpatrick, who will become CEO in March 2027. Tobin has over 35 years of experience and joined CME in 2002. CME also announced plans to enter the European dairy market by taking over EEX's dairy indices. CME shares were down slightly, with a 12% gain over the past year.

Hyperliquid and the Healthy Perps Coalition (HPC) filed an amicus brief supporting the CFTC's approval of perpetual futures contracts. The brief argues CME Group's lawsuit lacks standing and stifles innovation. HPC claims the CFTC's approval expanded the market, benefiting all exchanges. If CME succeeds, future innovations may face legal challenges, potentially slowing market development.

The Hyperliquid Policy Center filed an amicus brief supporting the CFTC in its legal dispute with CME Group, arguing that CME lacks standing and its interests fall outside the Commodity Exchange Act's protections. CME sued over the CFTC's approval of Kalshi's perpetual futures contract, claiming it should be classified as a swap. The CFTC and HPC contend CME's arguments are flawed and that the exchange could list similar products if it chose to. The case could impact the U.S. perpetual futures m

CME Group will enter the European dairy derivatives market, launching its own indices, futures, and options under an agreement with EEX. EEX plans to phase out its dairy business by the end of 2027. The transaction includes European butter and skimmed milk powder indices and is subject to closing conditions. CME cited the EU's significant role in global dairy production and exports, according to the USDA.

CME Group (CME) will acquire European Energy Exchange's (EEX) European dairy business, including butter and skimmed milk powder indices, by the end of 2027. CME plans to launch its own European dairy indices, futures, and options. The EU is a significant player in global dairy production and exports, according to the USDA. CME's stock was down 1.64% pre-market.

CME Group (CME) benefits from market uncertainty, as its futures and options exchanges see increased trading volume. Q2 2026 revenue was $1.7B, operating income $1.1B, and earnings $2.99 per share. August daily volume was up 6% YoY. CME pays a quarterly dividend of $1.30 and a variable dividend, totaling a 4.2% yield in 2025. The stock trades at ~24x earnings.